Brief: Scisparc-Clearmind File International Patent for Novel Obesity & Blood Sugar Therapy
07/08/2025 13:09
Aug 7 (Reuters) - Clearmind Medicine Inc CMND.O: SCISPARC-CLEARMIND COLLABORATION LEADS TO PUBLICATION OF INTERNATIONAL PATENT APPLICATION FOR NOVEL COMBINATION THERAPY TARGETING OBESITY AND HIGH BLOOD SUGAR Source text: ID:nGNX6YCMnd Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM